These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27223667)

  • 1. Donepezil as Add-on Treatment for Resistant Obsessive-Compulsive Disorder: Retrospective Case Series.
    Bergman J; Miodownik C; Lerner PP; Miodownik E; Shulkin A; Lerner V
    Clin Neuropharmacol; 2016; 39(4):194-6. PubMed ID: 27223667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amisulpride as add-on treatment for resistant obsessive-compulsive disorder: retrospective case series.
    Miodownik C; Bergman J; Lerner PP; Kreinin A; Lerner V
    Clin Neuropharmacol; 2015; 38(1):26-9. PubMed ID: 25580923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.
    Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T
    Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
    Feusner JD; Kerwin L; Saxena S; Bystritsky A
    Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
    Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
    Mazeh D; Zemishlani H; Barak Y; Mirecki I; Paleacu D
    Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-coping therapy for obsessive-compulsive disorder: a randomized controlled trial.
    Ma JD; Wang CH; Li HF; Zhang XL; Zhang YL; Hou YH; Liu XH; Hu XZ
    J Psychiatr Res; 2013 Nov; 47(11):1785-90. PubMed ID: 23988179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroacupuncture for refractory obsessive-compulsive disorder: a pilot waitlist-controlled trial.
    Zhang ZJ; Wang XY; Tan QR; Jin GX; Yao SM
    J Nerv Ment Dis; 2009 Aug; 197(8):619-22. PubMed ID: 19684500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limbic system surgery for treatment-refractory obsessive-compulsive disorder: a prospective long-term follow-up of 64 patients.
    Sheth SA; Neal J; Tangherlini F; Mian MK; Gentil A; Cosgrove GR; Eskandar EN; Dougherty DD
    J Neurosurg; 2013 Mar; 118(3):491-7. PubMed ID: 23240700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
    Keefe RS; Malhotra AK; Meltzer HY; Kane JM; Buchanan RW; Murthy A; Sovel M; Li C; Goldman R
    Neuropsychopharmacology; 2008 May; 33(6):1217-28. PubMed ID: 17625502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lurasidone as add-on to fluoxetine in obsessive-compulsive disorder with comorbid restrictive anorexia: a case report.
    Orsolini L; Bellagamba S; Volpe U
    Int Clin Psychopharmacol; 2024 May; 39(3):211-214. PubMed ID: 37556307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series.
    Dell'Osso B; Mundo E; Altamura AC
    CNS Spectr; 2006 Nov; 11(11):879-83; quiz 885. PubMed ID: 17075559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.
    George MS; Ward HE; Ninan PT; Pollack M; Nahas Z; Anderson B; Kose S; Howland RH; Goodman WK; Ballenger JC
    Brain Stimul; 2008 Apr; 1(2):112-21. PubMed ID: 20633378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.
    McDougle CJ; Barr LC; Goodman WK; Pelton GH; Aronson SC; Anand A; Price LH
    Am J Psychiatry; 1995 Dec; 152(12):1812-4. PubMed ID: 8526253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
    Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: a randomized controlled trial.
    Mansur CG; Myczkowki ML; de Barros Cabral S; Sartorelli Mdo C; Bellini BB; Dias AM; Bernik MA; Marcolin MA
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1389-97. PubMed ID: 21557884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L; Topuz A
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder.
    Oulis P; Mourikis I; Konstantakopoulos G
    Int Clin Psychopharmacol; 2011 Jul; 26(4):221-4. PubMed ID: 21460732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.